ArticleAmerican journal of translational research2024
Treatment effects of platelet-rich plasma combined with arthroscopic microfracture for knee cartilage injury.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Effectiveness of platelet-rich plasma plus microfracture compared with microfracture alone in the treatment of knee cartilage lesions: a systematic review and meta-analysis of comparative studies.International journal of surgery (London, England) · 2026Article
- Clinical efficacy of arthroscopic microfracture combined with sodium hyaluronate in the treatment of knee osteoarthritis.American journal of translational research · 2026Article
- Intraosseous and Intra-Articular Platelet-Rich Plasma for Severe Knee Osteoarthritis: A Real-World-Outcomes Initiative.Journal of clinical medicine · 2025Article
- From molecular mechanism to plant intervention: the bidirectional regulation of inflammation and oxidative stress in bone aging.Frontiers in endocrinology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the clinical effects of platelet-rich plasma (PRP) combined with arthroscopic microfracture (MF) in patients with knee cartilage injury.
methodsEighty cases of knee cartilage injury treated in Lu'an Hospital of PKU HealthCare during July 2019 and July 2021 were selected for this study. Patients were divided into a control group (CG, treated with MF alone, n=36) and an observation group (OG, treated with MG+PRP, n=44) based on their intervention regimen. Outcomes were compared between the two groups, including Hospital for Special Surgery (HSS) score, Tegner Activity Scale (TAS) score, Berg Balance Scale (BBS) score (joint balance function), Visual Analogue Scale (VAS) score, and Short-Form 36 Item Health Survey (SF-36) score, as well as levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and matrix metalloproteinase (MMP)-13. Furthermore, a binary logistic regression analysis was conducted to identify the factors influencing treatment efficacy in patients with knee cartilage injuries.
resultsThe overall response rate was significantly higher in the OG than in the CG. Factors such as sex, age, disease duration, lesion location, ICRS (International Cartilage Repair Society) grade, and treatment modality did not significantly affect treatment efficacy. The OG showed elevated HSS, TAS, and BBS scores after treatment, compared to baseline and the CG. Additionally, VAS scores and levels of TNF-α, IL-1β, and MMP-13 were notably lower compared with the baseline and the CG. In terms of life quality, patients in the OG scored markedly higher in dimensions of vitality, physiological function and social function, compared to both the pre-treatment values and CG.
conclusionsPRP combined with MF outperformed MF alone in treating knee cartilage injury, which greatly improves patients' knee joint function and balance function, reduces pain, inhibits inflammation in the joint cavity, and enhances overall quality of life, with a favorable safety profile.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.